Source: CITE
Selected African countries preparing to roll out the new HIV prevention drug, Lenacapavir, are being urged to actively share lessons and implementation strategies, as global health leaders emphasise that knowledge exchange will be critical to maximising the impact of the vaccine. The call was made during a digital press briefing hosted by the U.S. Department of State’s Africa Regional Media […].
